224 related articles for article (PubMed ID: 16830791)
1. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
3. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme].
Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119
[TBL] [Abstract][Full Text] [Related]
4. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme.
Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G
Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919
[TBL] [Abstract][Full Text] [Related]
5. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
[TBL] [Abstract][Full Text] [Related]
6. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
[TBL] [Abstract][Full Text] [Related]
7. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X
J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
9. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
[TBL] [Abstract][Full Text] [Related]
10. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
[TBL] [Abstract][Full Text] [Related]
11. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
12. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
13. Screening of deoxyribozyme with high reversal efficiency against multidrug resistance in breast carcinoma cells.
Gao P; Wei JM; Li PY; Zhang CJ; Jian WC; Zhang YH; Xing AY; Zhou GY
J Cell Mol Med; 2011 Oct; 15(10):2130-8. PubMed ID: 21155975
[TBL] [Abstract][Full Text] [Related]
14. Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene.
Qia S; Wang H; Chen X
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):662-4. PubMed ID: 16696319
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro.
Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo.
Lu S; Huang Q; Wang Z; Song Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):620-4. PubMed ID: 19821097
[TBL] [Abstract][Full Text] [Related]
17. Overcoming multi-drug resistance by anti-MDR1 ribozyme.
Wang H; Chen XP; Qiu FZ
World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138
[TBL] [Abstract][Full Text] [Related]
18. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
20. Effect of fractionated irradiation on the expression of multidrug resistance genes in the CNE1 human nasopharyngeal carcinoma cell line.
Ji XN; Yang F; Sui XM; Wang FG; Ge RG; Quan XL; Zhao T; Gao BW; Wang RY
Mol Med Rep; 2013 Jan; 7(1):187-94. PubMed ID: 23128850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
